The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Resistance to Antibiotics Mediated by Target Alterations
Abstract
The development of resistance to antibiotics by reductions in the affinities of their enzymatic targets occurs most rapidly for antibiotics that inactivate a single target and that are not analogs of substrate. In these cases of resistance (for example, resistance to rifampicin), numerous single amino acid substitutions may provide large decreases in the affinity of the target for the antibiotic, leading to clinically significant levels of resistance. Resistance due to target alterations should occur much more slowly for those antibiotics (penicillin, for example) that inactivate multiple targets irreversibly by acting as close analogs of substrate. Resistance to penicillin because of target changes has emerged, by unexpected mechanisms, only in a limited number of species. However, inactivating enzymes commonly provide resistance to antibiotics that, like penicillin, are derived from natural products, although such enzymes have not been found for synthetic antibiotics. Thus, the ideal antibiotic would be produced by rational design, rather than by the modification of a natural product.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The crisis in antibiotic resistance
Neu, H. C. (1992) · Science · doi:10.1126/science.257.5073.1064 · Cited by 2,834
Smith, J. M., Smith, N. H., O'Rourke, M., & Spratt, B. G. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.10.4384 · Cited by 1,802
Self-citationInactivation of Antibiotics and the Dissemination of Resistance Genes
Davies, J. (1994) · Science · doi:10.1126/science.8153624 · Cited by 1,730
Prevention of Drug Access to Bacterial Targets: Permeability Barriers and Active Efflux
Nikaido, H. (1994) · Science · doi:10.1126/science.8153625 · Cited by 1,540
Structure-Based Strategies for Drug Design and Discovery
Kuntz, I. D. (1992) · Science · doi:10.1126/science.257.5073.1078 · Cited by 989
Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli
Yoshida, H., Bogaki, M., Nakamura, M., Yamanaka, L. M., & Nakamura, S. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.8.1647 · Cited by 777
Rayssiguier, C., Thaler, D. S., & Radman, M. (1989) · Nature · doi:10.1038/342396a0 · Cited by 721
Jin, D. J., & Gross, C. A. (1988) · Journal of Molecular Biology · doi:10.1016/0022-2836(88)90517-7 · Cited by 683
SERINE β-LACTAMASES AND PENICILLIN-BINDING PROTEINS
Ghuysen, J.-M. (1991) · Annual Review of Microbiology · doi:10.1146/annurev.mi.45.100191.000345 · Cited by 628
Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli
Yoshida, H., Bogaki, M., Nakamura, M., & Nakamura, S. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.6.1271 · Cited by 570
Cited by
Antibacterial resistance worldwide: causes, challenges and responses
Levy, S. B., & Marshall, B. (2004) · Nature Medicine · doi:10.1038/nm1145 · Cited by 4,052
Multidrug Resistance in Bacteria
Nikaido, H. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.082907.145923 · Cited by 1,682
Characterization of the action of selected essential oil components on Gram-negative bacteria
Helander, I. M., Alakomi, H.-L., Latva-Kala, K., Mattila-Sandholm, T., Pol, I., Smid, E. J., Gorris, L. G. M., & von Wright, A. (1998) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf980154m · Cited by 1,664
Molecular mechanisms that confer antibacterial drug resistance
Walsh, C. (2000) · Nature · doi:10.1038/35021219 · Cited by 1,578
Prevention of Drug Access to Bacterial Targets: Permeability Barriers and Active Efflux
Nikaido, H. (1994) · Science · doi:10.1126/science.8153625 · Cited by 1,540
Challenges of Antibacterial Discovery
Silver, L. L. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00030-10 · Cited by 1,376
Acquired Antibiotic Resistance Genes: An Overview
van Hoek, A. H. A. M., Mevius, D., Guerra, B., Mullany, P., Roberts, A. P., & Aarts, H. J. M. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00203 · Cited by 1,136
Perspectives on the use of organic acids and short chain fatty acids as antimicrobials
Ricke, S. (2003) · Poultry Science · doi:10.1093/ps/82.4.632 · Cited by 1,030
Vaou, N., Stavropoulou, E., Voidarou, C., Tsigalou, C., & Bezirtzoglou, E. (2021) · Microorganisms · doi:10.3390/microorganisms9102041 · Cited by 993
Review on plant antimicrobials: a mechanistic viewpoint
Khameneh, B., Iranshahy, M., Soheili, V., & Fazly Bazzaz, B. S. (2019) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-019-0559-6 · Cited by 891
Davey, H. M., & Kell, D. B. (1996) · Microbiological Reviews · doi:10.1128/mr.60.4.641-696.1996 · Cited by 879
Molecular Properties of Bacterial Multidrug Transporters
Putman, M., van Veen, H. W., & Konings, W. N. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.4.672-693.2000 · Cited by 795
Bacteriophage Endolysins as Novel Antimicrobials
Schmelcher, M., Donovan, D. M., & Loessner, M. J. (2012) · Future Microbiology · doi:10.2217/fmb.12.97 · Cited by 785
Shlaes, D. M., Gerding, D. N., John, Jr., Craig, W. A., Bornstein, D. L., Duncan, R. A., Eckman, M. R., Farrer, W. E., Greene, W. H., Lorian, V., et al. (1997) · Clinical Infectious Diseases · doi:10.1086/513766 · Cited by 780
Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment
Shaikh, S., Fatima, J., Shakil, S., Rizvi, S. M. D., & Kamal, M. A. (2015) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2014.08.002 · Cited by 758
The future challenges facing the development of new antimicrobial drugs
Coates, A., Hu, Y., Bax, R., & Page, C. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd940 · Cited by 704
Biocontrol of Soilborne Plant Pathogens.
Handelsman, J., & Stabb, E. V. (1996) · The Plant Cell · doi:10.1105/tpc.8.10.1855 · Cited by 624
Gupta, R. S. (1998) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.62.4.1435-1491.1998 · Cited by 598
Bacterial Resistance: Origins, Epidemiology, and Impact
Livermore, D. M. (2003) · Clinical Infectious Diseases · doi:10.1086/344654 · Cited by 586
Terpene Derivatives as a Potential Agent against Antimicrobial Resistance (AMR) Pathogens
Mahizan, N. A., Yang, S.-K., Moo, C.-L., Song, A. A.-L., Chong, C.-M., Chong, C.-W., Abushelaibi, A., Lim, S.-H. E., & Lai, K.-S. (2019) · Molecules · doi:10.3390/molecules24142631 · Cited by 473
Penicillin Binding Proteins: key players in bacterial cell cycle and drug resistance processes
Macheboeuf, P., Contreras-Martel, C., Job, V., Dideberg, O., & Dessen, A. (2006) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2006.00024.x · Cited by 447
Simões, M., Bennett, R. N., & Rosa, E. A. S. (2009) · Natural Product Reports · doi:10.1039/b821648g · Cited by 444
Antagonistic Interactions among Marine Pelagic Bacteria
Long, R. A., & Azam, F. (2001) · Applied and Environmental Microbiology · doi:10.1128/aem.67.11.4975-4983.2001 · Cited by 413
Mutant Selection Window Hypothesis Updated
Drlica, K., & Zhao, X. (2007) · Clinical Infectious Diseases · doi:10.1086/511642 · Cited by 383
Grams, R. J., Santos, W. L., Scorei, I. R., Abad-García, A., Rosenblum, C. A., Bita, A., Cerecetto, H., Viñas, C., & Soriano-Ursúa, M. A. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00663 · Cited by 377
Sayah, R. S., Kaneene, J. B., Johnson, Y., & Miller, R. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.3.1394-1404.2005 · Cited by 369
The phylogeny of proteobacteria: relationships to other eubacterial phyla and eukaryotes
Gupta, R. S. (2000) · FEMS Microbiology Reviews · doi:10.1016/s0168-6445(00)00031-0 · Cited by 363
Shan, B., Cai, Y.-Z., Brooks, J. D., & Corke, H. (2007) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf070424d · Cited by 362
Vancomycin Assembly: Nature's Way
Hubbard, B. K., & Walsh, C. T. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200390202 · Cited by 356
Multidrug-Resistant Mycobacterium tuberculosis: Molecular Perspectives
Rattan, A., Kalia, A., & Ahmad, N. (1998) · Emerging Infectious Diseases · doi:10.3201/eid0402.980207 · Cited by 355
Diversity of PspA: Mosaic Genes and Evidence for Past Recombination in Streptococcus pneumoniae
Hollingshead, S. K., Becker, R., & Briles, D. E. (2000) · Infection and Immunity · doi:10.1128/iai.68.10.5889-5900.2000 · Cited by 339
Lubelski, J., Konings, W. N., & Driessen, A. J. M. (2007) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00001-07 · Cited by 339
Recombination and the Population Structures of Bacterial Pathogens
Feil, E. J., & Spratt, B. G. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.561 · Cited by 336
Self-citationCarbapenemases: a problem in waiting?
Livermore, D. M., & Woodford, N. (2000) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(00)00128-4 · Cited by 323
Evolution in Health and Disease
(2007) · doi:10.1093/acprof:oso/9780199207466.001.0001 · Cited by 320
Multi-targeting by monotherapeutic antibacterials
Silver, L. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2202 · Cited by 311
Knox, J. R. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.12.2593 · Cited by 311
Antibiotic Resistance in Bacteria and Its Future for Novel Antibiotic Development
YONEYAMA, H., & KATSUMATA, R. (2006) · Bioscience, Biotechnology, and Biochemistry · doi:10.1271/bbb.70.1060 · Cited by 286
Activity of plant flavonoids against antibiotic-resistant bacteria
Xu, H.-X., & Lee, S. F. (2001) · Phytotherapy Research · doi:10.1002/1099-1573(200102)15:1<39::aid-ptr684>3.0.co;2-r · Cited by 282
Mussi, M. A., Limansky, A. S., & Viale, A. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1432-1440.2005 · Cited by 276
A novel mechanism underlying drug resistance in chronic epilepsy
Remy, S., Gabriel, S., Urban, B. W., Dietrich, D., Lehmann, T. N., Elger, C. E., Heinemann, U., & Beck, H. (2003) · Annals of Neurology · doi:10.1002/ana.10473 · Cited by 275
Beta‐lactamases and bacterial resistance to antibiotics
Frère, J. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.tb02404.x · Cited by 263
Antibacterial Activity of Coriander Volatile Compounds against Salmonella choleraesuis
Kubo, I., Fujita, K.-I., Kubo, A., Nihei, K.-I., & Ogura, T. (2004) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0354186 · Cited by 262
Renau, T. E., Léger, R., Flamme, E. M., Sangalang, J., She, M. W., Yen, R., Gannon, C. L., Griffith, D., Chamberland, S., Lomovskaya, O., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9904598 · Cited by 260
Riedel, D. J., Weekes, E., & Forrest, G. N. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00300-08 · Cited by 136
“aureus infections (15, 28), and it has recently been shown at the genetic level to occur after only a single dose of rifampin in a patient with MRSA endocarditis (24).”
BackgroundTransferrin iron starvation therapy for lethal bacterial and fungal infections
Lin, L., Pantapalangkoor, P., Tan, B., Bruhn, K. W., Ho, T., Nielsen, T., Skaar, E. P., Zhang, Y., Bai, R., Wang, A., et al. (2014) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu049 · Cited by 68
Transferrin-mediated iron sequestration as a novel therapy for bacterial and fungal infections
Bruhn, K. W., & Spellberg, B. (2015) · Current Opinion in Microbiology · doi:10.1016/j.mib.2015.07.005 · Cited by 48
Teodoro, J. C., Baptista-Neto, A., Cruz-Hernández, I. L., Hokka, C. O., & Badino, A. C. (2006) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-005-0273-6 · Cited by 42
“Although antibiotics have been effective in the treatment of infections, resistance is an inevitable consequence of selective pressures imposed by the widespread use and misuse of antibiotics (Sanders and Sanders 1979; Spratt 1994 ).”
BackgroundPATHOGENS RESISTANT TO ANTIMICROBIAL AGENTS
Fraimow, H. S., & Abrutyn, E. (1995) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(20)30683-8 · Cited by 37
Qvarnström, Y., & Swedberg, G. (2000) · Microbiology · doi:10.1099/00221287-146-5-1151 · Cited by 24
(2003) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11
Metadata
- Authors
- Spratt, B. G.
- Venue
- Science
- Published
- 1994-04-15
- Volume
- 264
- Issue
- 5157
- Pages
- 388-393
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2082064308
- Cited by
- 674
- References
- 48
- FWCI
- 18.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.